Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Stock Up ∞
The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The firm has a 50 day moving average of C$2.00 and a two-hundred day moving average of C$2.00. The firm has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Energy and Oil Stocks Explained
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Invest in Biotech Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
